Skip to main navigation
Skip to search
Skip to main content
King's College London Home
Home
Profiles
Research units
Research output
Projects
Student theses
Activities
Datasets
Impacts
Prizes
Search by expertise, name or affiliation
Cancer Imaging
Life Sciences & Medicine
Biomedical Engineering & Imaging Sciences
Overview
Fingerprint
Network
Profiles
(30)
Research output
(1206)
Projects
(133)
Activities
(53)
Student theses
(18)
Prizes
(14)
Research output
Research output per year
1988
2001
2012
2019
2020
2021
2022
2023
2024
2025
48440
Citations
819
Article
114
Meeting abstract
61
Review article
49
Literature review
163
More
33
Editorial
32
Letter
31
Chapter
24
Conference paper
12
Comment/debate
6
Book
6
Meeting Abstract
6
Poster abstract
5
Abstract
2
Poster
2
Preprint
1
Conference contribution
1
Paper
1
Short survey
1
Featured article
Research output per year
Research output per year
2 results
Publication Year, Title
(descending)
Publication Year, Title
(ascending)
Title
Type
Filter
Poster
Search results
2022
Characteristics and survival of advanced non-small cell lung cancer (NSCLC) in young Black patients: a Guy’s Cancer Centre real-world study.
Hughes, D.
,
Kapiris, M.
, Podvez Nevajda, A.,
Stavraka, C.
,
Cook, G.
,
Josephs, D.
, Ghosh, S., Pintus, E., Gennatas, S., Ahmed, S.,
Santis, G.
,
Ryanna, K.
, Montes, A., Smith, D., Karapanagiotou, E.,
Van Hemelrijck, M.
,
Spicer, J.
& Georgiou, A.,
Oct 2022
.
Research output
:
Contribution to conference types
›
Poster
›
peer-review
File
Clinical Trial
100%
Overall Survival
100%
Malignant Neoplasm
100%
Non Small Cell Lung Cancer
100%
Prospective Cohort Study
50%
87
Downloads (Pure)
2019
PECan study, imaging PD-L1 in cancer: A tool for measuring response to immunotherapy?
Hughes, D.
, Chand, G.,
Josephs, D.
,
Harries, M.
,
Papa, S.
,
Spicer, J.
, Ting, H. H.,
Goh, V.
&
Cook, G.
,
2019
,
p. XI61
.
Research output
:
Contribution to conference types
›
Poster
›
peer-review
Open Access
Malignant Neoplasm
100%
Programmed Death-Ligand 1
100%
Immunotherapy
100%
Technetium-99
28%
Non Small Cell Lung Cancer
21%